4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-012826
Director sold 15,470 shares at an average $328.54 ($5,082,480)
- Director acquired 15,470 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CRAVES FRED B Director | 2025-03-12 | Option exercise | +1,728 | $65.06 | $112,424 | 351,804 | D |
| CRAVES FRED B Director | 2025-03-12 | Option exercise | +6,000 | $111.06 | $666,360 | 357,804 | D |
| CRAVES FRED B Director | 2025-03-12 | Sale | −1,587 | $330.54 | $524,560 | 356,217 | D |
| CRAVES FRED B Director | 2025-03-12 | Sale | −2,759 | $331.36 | $914,221 | 353,458 | D |
| CRAVES FRED B Director | 2025-03-12 | Sale | −2,382 | $332.38 | $791,726 | 351,076 | D |
| CRAVES FRED B Director | 2025-03-12 | Sale | −800 | $333.66 | $266,926 | 350,276 | D |
| CRAVES FRED B Director | 2025-03-12 | Sale | −200 | $334.97 | $66,994 | 350,076 | D |
| CRAVES FRED B Director | 2025-03-13 | Option exercise | +7,742 | $65.06 | $503,695 | 357,818 | D |
| CRAVES FRED B Director | 2025-03-13 | Sale | −1,951 | $322.45 | $629,100 | 355,867 | D |
| CRAVES FRED B Director | 2025-03-13 | Sale | −1,649 | $323.47 | $533,394 | 354,218 | D |
| CRAVES FRED B Director | 2025-03-13 | Sale | −900 | $324.69 | $292,218 | 353,318 | D |
| CRAVES FRED B Director | 2025-03-13 | Sale | −800 | $325.63 | $260,501 | 352,518 | D |
| CRAVES FRED B Director | 2025-03-13 | Sale | −1,000 | $327.63 | $327,627 | 351,518 | D |
| CRAVES FRED B Director | 2025-03-13 | Sale | −400 | $328.68 | $131,472 | 351,118 | D |
| CRAVES FRED B Director | 2025-03-13 | Sale | −967 | $329.86 | $318,975 | 350,151 | D |
| CRAVES FRED B Director | 2025-03-13 | Sale | −75 | $330.23 | $24,767 | 350,076 | D |
| Derivatives | |||||||
| CRAVES FRED B Director | 2025-03-12 | Option exercise · Stock Option (Right to Buy) | −1,728 | 7,742 | D | ||
| CRAVES FRED B Director | 2025-03-12 | Option exercise · Stock Option (Right to Buy) | −6,000 | 0 | D | ||
| CRAVES FRED B Director | 2025-03-13 | Option exercise · Stock Option (Right to Buy) | −7,742 | 0 | D | ||
| Open-market sales · 15,470 sh · avg $328.54 · $5,082,480 | |||||||
Loading xslF345X05/wk-form4_1741983899.xml…